Thailand In Vitro Diagnostics Market

Snapshot of Demand and Investment Opportunities

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
15-Nov-2014
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P85D-01-00-00-00
SKU
LS00060-AP-MR_16901
Yes
SHARE

Thailand In Vitro Diagnostics Market
Published on: 15-Nov-2014 | SKU: LS00060-AP-MR_16901

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years’ business plan. Segments in the market include molecular diagnostics, immunochemistry, and microbiology. Market revenues, prevalence, test volumes, and market share are included in this deliverable. With the exception of prevalence (base year of 2012), the base year is 2013 with 2014–2019 as the forecast period. This report also provides a broad insight into the socio-political scenario and economy of the country to help international companies in their decision.


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and microbiology. Market revenues, prevalence, test volumes, and market share are included in this deliverable. With the exception of prevalence (base year of 2012), the base year is 2013 with 20142019 as the forecast period. This report also provides a broad insight into the socio-political scenario and economy of the country to help international companies in their decision.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Siddharth Dutta
WIP Number P85D-01-00-00-00
Is Prebook No

Thailand In Vitro Diagnostics Market

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
LS00060-AP-MR_16901